dopamine antagonist - chemicals which reduce amount of nt
reduce dopamine activity by blocking dopamine receptors at synapse
reduces positive symptoms - hallucinations
calming/sedative effect
atypical antipsychotics?
newer medication introduced in 1990s
acts on dopamine & serotonin
reduce dopamine activity by blocking dopamine receptors at synapse
increases serotonin
reduces positive symptoms - hallucinations
reduces negative symptoms - avolition
calming/sedative effect
2 * for drug therapy?
evidence to support effectiveness from davis
cheap & easy to administer
3 X for drug therapy?
high relapse rates
cannot give informed consent
side effects
* evidence to support from davis?
davis 1989 conducted meta analysis of over 100 studies that compared effectiveness of antipsychotic drugs with placebos
over 70% patients treated with drug improved after 6 weeks
only 25% improved with placebo
effective
altering levels of dopamine through use of antipsychotic drugs causes clear reduction of symptoms for majority of patients compared to placebo effect short term
means treatment works & biological approach to treating sz is accurate
X not 100% for davis?
research highlights that not everyonebenefits from antipsychotics
effective for 70% showing that 30% people do not show improvements from taking drugs
? effective
does not improve everyones symptoms so may be better treatments that are more effective for wider sz population
X high relapse rates?
research has shown that 40%likelihood that sz patient will relapse within first year of taking antipsychotics & 15% relapse rates in later years
? effective
shows it isnt effective in helping patients with sz in longterm
may be better therapy to give lastingeffects
* cheap & easy to administer?
taking drug is quick & simple as it only involves swallowing tablet
also cheap to obtain & can be readilyavailable for nhs
suitable for wider range of individuals compared to psychological therapies such as cbt & familytherapy which may be cognitivelydemanding
appropriate
due to low cost implications & being easy to do more people can successfullyaccess it increasing likelihood of being a chosen treatment for patients
X cannot give informed consent?
people with sz often suffer from hallucinations & delusions - delusions of persecution
fear someone will hurt them so may not be in right frame of mind to give informed consent as they may think treatment is made to harm them
? appropriate
patients with sz cant always give fully informed consent for accepting treatment & unethical to administer/difficult to ensure patients want to get on board with it
another treatment may be more appropriate
X side effects?
mild to serious
typical - produce movement side effects resembles parkinsons disease - tardive dyskinesia
15% long term users will develop this serious side effect
tardile - delayed - sudden movements of face & body thats not controlled
potentially permenant
lack of control of face - issues w communication increasing severity of neg symptoms - speech poverty
atypical - weight gain/cardiovascular problems
causes side effects that make patient worse than before
comorbidly suffering from additional disorder & lead to severe side effects for people who take them for severe sz